NOVO NORDISK A S (NVO) reporting calendar
NOVO NORDISK A S files periodic reports with the SEC as NVO on NYSE. Atlas tracks 11 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 4 Feb 2026
- Reports on record
- 11
Open NVO market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll NYSE reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 4 Feb 2026 | 35 days | 0000353278-26-000012 |
| 20-F | 31 Dec 2024 | 5 Feb 2025 | 36 days | 0001628280-25-003920 |
| 20-F | 31 Dec 2023 | 31 Jan 2024 | 31 days | 0001628280-24-002635 |
| 20-F | 31 Dec 2022 | 1 Feb 2023 | 32 days | 0001628280-23-001868 |
| 20-F | 31 Dec 2021 | 2 Feb 2022 | 33 days | 0001628280-22-001639 |
| 20-F | 31 Dec 2020 | 3 Feb 2021 | 34 days | 0001628280-21-001364 |
| 20-F | 31 Dec 2019 | 5 Feb 2020 | 36 days | 0001628280-20-001021 |
| 20-F | 31 Dec 2018 | 4 Feb 2019 | 35 days | 0001628280-19-000875 |
| 20-F | 31 Dec 2017 | 8 Feb 2018 | 39 days | 0001628280-18-001266 |
| 20-F | 31 Dec 2016 | 9 Feb 2017 | 40 days | 0001171843-17-000780 |
| 20-F | 31 Dec 2015 | 10 Feb 2016 | 41 days | 0001171843-16-007795 |
Source: SEC EDGAR company submissions for CIK 0000353278. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.